Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

McKinsey
Mallinckrodt
Healthtrust
US Department of Justice
Chubb
QuintilesIMS
Baxter
UBS
Deloitte

Generated: April 20, 2018

DrugPatentWatch Database Preview

AQUATENSEN Drug Profile

« Back to Dashboard

Which patents cover Aquatensen, and when can generic versions of Aquatensen launch?

Aquatensen is a drug marketed by Medpointe Pharm Hlc and is included in one NDA.

The generic ingredient in AQUATENSEN is methyclothiazide. There are two drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the methyclothiazide profile page.
Drug patent expirations by year for AQUATENSEN
Medical Subject Heading (MeSH) Categories for AQUATENSEN
Synonyms for AQUATENSEN
(+-)-6-Chloro-3-(chloromethyl)-3,4-dihydro-2-methyl-2H-1,2,4-benzothiadiazine-7-sulfonamide 1,1-dioxide
135-07-9
135M079
2-methyl-,1,1-dioxide
2H-1,2,4-Benzothiadiazine-7-sulfonamide, 6-chloro-3-(chloromethyl)-3,4-dihydro-,1,1-dioxide
2H-1,2,4-Benzothiadiazine-7-sulfonamide, 6-chloro-3-(chloromethyl)-3,4-dihydro-2-methyl-, 1,1-dioxid
2H-1,2,4-Benzothiadiazine-7-sulfonamide, 6-chloro-3-(chloromethyl)-3,4-dihydro-2-methyl-, 1,1-dioxide
2H-1,2,4-Benzothiadiazine-7-sulfonamide, 6-chloro-3-(chloromethyl)-3,4-dihydro-2-methyl-, 1,1-dioxide, (+-)-
2H-1,4-Benzothiadiazine-7-sulfonamide, 6-chloro-3-(chloromethyl)-3,4-dihydro-2-methyl-, 1,1-dioxide
4-benzothiadiazine-7-sulfonamide,6-chloro-3-(chloromethyl)-3,4-dihydro-2h-2
6-chloranyl-3-(chloromethyl)-2-methyl-1,1-bis(oxidanylidene)-3,4-dihydro-1$l^{6},2,4-benzothiadiazine-7-sulfonamide
6-chloro-3-(chloromethyl)-2-methyl-1,1-dioxo-3,4-dihydro-1
6-chloro-3-(chloromethyl)-2-methyl-1,1-dioxo-3,4-dihydro-1?^{6},2,4-benzothiadiazine-7-sulfonamide
6-chloro-3-(chloromethyl)-2-methyl-1,1-dioxo-3,4-dihydro-1$l^{6},2,4-benzothiadiazine-7-sulfonamide
6-chloro-3-(chloromethyl)-2-methyl-1,1-dioxo-3,4-dihydro-2H-1??,2,4-benzothiadiazine-7-sulfonamide
6-chloro-3-(chloromethyl)-2-methyl-1,1-dioxo-3,4-dihydro-2H-1$l;{6},2,4-benzothiadiazine-7-sulfonamide
6-chloro-3-(chloromethyl)-2-methyl-1,1-dioxo-3,4-dihydro-2H-1lambda,2,4-benzothiadiazine-7-sulfonamide
6-chloro-3-(chloromethyl)-2-methyl-1,1-dioxo-3,4-dihydro-2H-1lambda6,2,4-benzothiadiazine-7-sulfonamide
6-Chloro-3-(chloromethyl)-2-methyl-3,4-dihydro--2H-1,2,4-benzothiadiazine-7-sulfonamide 1,1-dioxide
6-Chloro-3-(chloromethyl)-2-methyl-3,4-dihydro-2H-1,2,4-benzothiadiazine-7-sulfonamide 1,1-dioxide
6-Chloro-3-(chloromethyl)-2-methyl-3,4-dihydro-2H-1,2,4-benzothiadiazine-7-sulfonamide 1,1-dioxide #
6-chloro-3-(chloromethyl)-2-methyl-3,4-dihydro-2H-benzo[e][1,2,4]thiadiazine-7-sulfonamide 1,1-dioxide
6-Chloro-3-(chloromethyl)-3,2,4-benzothiadiazine-7-sulfonamide 1,1-dioxide
6-Chloro-3-(chloromethyl)-3,4-dihydro-2-methyl-2H-1,2, 4-benzothiadiazine-7-sulfonamide 1,1-dioxide
6-chloro-3-(chloromethyl)-3,4-dihydro-2-methyl-2h-1,2,4-benzothiadiazine-7-sul
6-Chloro-3-(chloromethyl)-3,4-dihydro-2-methyl-2H-1,2,4-benzothiadiazine-7-sulfonamide 1,1-dioxide
6-chloro-3-chloromethyl-2-methyl-7-sulfamyl-3,4-dihydro-1,2,4-benzothiadiazine
6-Chloro-3-chloromethyl-2-methyl-7-sulfamyl-3,4-dihydro-1,2,4-benzothiadiazine 1,1-dioxide
6-chloro-3-chloromethyl-3,4-dihydro-2-methyl-7-sulfamoyl-1,2,4-benzothiadiazin
96783-15-2
A806880
AB0012760
AB01014600_03
AB01014600_04
AC1L1HGJ
AC1Q6TPS
AKOS015896465
AN-43749
Aquaresen
AS-12982
BC252769
BRN 0765361
C07765
C9H11Cl2N3O4S2
CAS-135-07-9
CCG-213705
CESYKOGBSMNBPD-UHFFFAOYSA-N
CHEBI:6847
CHEMBL1577
CI-625
Ciba 7272-Su
ciba7272-su
CS-2671
D00656
D03GVC
DB00232
DSSTox_CID_3313
DSSTox_GSID_23313
DSSTox_RID_76970
DTXSID6023313
Duretic
EINECS 205-172-2
Enduron
Enduron (TN)
Enduronum
FT-0654252
GTPL7235
HE064508
HE307695
HMS3264D19
HMS3652E06
HSDB 3363
HY-B0562
I06-1878
KS-5138
LS-40433
MCULE-4894694501
Methychlothiazide
Methyclothiazid
methyclothiazide
Methyclothiazide (JAN/USP/INN)
Methyclothiazide [USAN:INN:BAN:JAN]
Methyclothiazidum
Methyclothiazidum [INN-Latin]
Methycyclothiazide
Methylchlorothiazide
METHYLCLOTHIAZIDE
Methylcyclothiazide
Meticlotiazida
Meticlotiazida [INN-Spanish]
Meticlotiazide
Meticlotiazide [DCIT]
MLS002704228
MolPort-006-110-909
Naturon
Naturon (VAN)
NCGC00167446-01
NCGC00167446-02
NE47692
NSC 110431
NSC-110431
NSC-760078
NSC110431
NSC760078
Pharmakon1600-01503841
s4057
SBB070984
SCHEMBL49396
SMR001550236
Tox21_112450
Tox21_112450_1
VA11285
WLN: T66 BSWN EM DHJ C1 D1G HG ISZW
Z1550675459

US Patents and Regulatory Information for AQUATENSEN

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Medpointe Pharm Hlc AQUATENSEN methyclothiazide TABLET;ORAL 017364-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Moodys
Teva
Accenture
Chubb
Harvard Business School
Argus Health
Chinese Patent Office
Deloitte
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.